home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Assisting Hands Home Care, LLC

SHARESHARESHARE
Assisting Hands® Home Care provides in-home care to a large population including the elderly, disabled, and others in need of assistance with the Activities of Daily Living in the comfort and security of their own home. Assisting Hands® was founded in 1996 with it's flagship locations in Phoenix, AZ and Boise ID and began franchising in 2006. Since inception, the company has grown to include more than 99 franchised territories in 16 states across the US and 1 Canadian province. The vision of excellence and passion for quality in-home care for those in need drives us to serve our clients like none other.
SHARESHARESHARE

RELATED NEWS


The Sheffield Institute for Translational Neuroscience (SITraN), part of the University of Sheffield and one of the world’s leading centres for research into Motor Neurone Disease, Alzheimer’s and Parkinson’s Disease....

READ MORE

Exelixis’ cancer drug Cabometyx has been approved in a new liver cancer use in the US, providing a second line therapy option for patients previously treated with Bayer’s Nexavar. The FDA has approved Cabometyx (cabozantinib) for patients with hepatocellular carcinoma (HCC) who have been previously treated with Nexavar (sorafenib). HCC is the most common form of liver cancer and the fastest rising cause of cancer-related death in the US, the company noted. Approval was based on resul...

READ MORE

Celgene has struck another collaborative deal, even as the large pharmaceutical company is in the process of being folded into the operations of its new owner, Bristol-Myers Squibb. This morning, privately-owned drug developer Triphase Accelerator, along with its majority shareholder FACIT, announced it had struck a collaborative deal with Celgene. The companies will harness their knowledge and resources to develop a first-in-class preclinical therapeutic targeting the WDR5 protein for the treat...

READ MORE

Older adults with more ideal measures of cardiovascular health were less likely to develop dementia and experience cognitive decline. This was the main finding of a recent study now published in JAMA that followed 6,626 people aged 65 and over in France for an average of 8.5 years. It based the cardiovascular health measures on the American Heart Association (AHA) "Simple 7" guide. The guide recommends: giving up smoking; being physically active; having a diet rich in vegetables, fruit...

READ MORE

According to a report in CNBC on Friday, the invitation-only summit is part of an initiative for advertisers called “Facebook Health”, run by a small team reporting into former Google Director Meredith Guerriero. The summit primarily focuses on gearing marketers in the pharmaceutical industry....

READ MORE

Grifols, a global healthcare company and one of world's top producers of plasma-derived medicines, today announced it has executed purchase arrangements with the South Korean-based GC Pharma (Group) whereby Grifols will acquire the Montreal-based plasma fractionation facility and two purification facilities, along with 11 U.S.-based plasma collection centers for a total amount of US$460 million.

The transaction is part of Grifols' sustainable global growth strategy to expa...

PR NEWSWIRE
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...